“…Owing to its preference for growth inhibition in the intestine, members of the TGF-b signaling pathway are targets for disruption in colorectal carcinogenesis (Fearon and Vogelstein, 1990). Most commonly mutated is TbRII, followed by Smad2 and Smad4 (Grady, 1998;Massague et al, 2000).…”